BIOMAT Database Logo BIOMAT Database Logo

Activation of the alternative complement pathway by Agaricus blazei Murill. 2002

S Shimizu, and H Kitada, and H Yokota, and J Yamakawa, and T Murayama, and K Sugiyama, and H Izumi, and N Yamaguchi
Department of Serology & Microbiology, Kanazawa Medical University, Uchinada, Ishikawa, Japan. shi-shi@kanazawa-med.ac.jp

Components of Agaricus blazei Murill have been demonstrated to have a wide range of immunopotentiating activities. The present study was designed to evaluate the effect of A. blazei Murill upon activation of the complement system in human serum in vitro. Additional studies were performed to determine the cytotoxic effect of complement-opsonized particles of A. blazei Murill against human tumor cells in culture. A fine particle of A. blazei Murill (ABP), prepared by mechanical disruption, was used throughout the experiments. ABP activated the human complement system via the alternative pathway in human serum. Activation of the alternative pathway was both time- and dose-dependent. When the particles from fruiting bodies of A. blazei Murill (ABP-F) were reacted with human serum, the formation of complement-opsonized ABP, iC3b-ABP-F complexes, and binding of the complexes to human peripheral blood monocytes, were demonstrated in vitro by immunofluorescence. Further, the resident human peripheral nucleated cells incubated in the presence of iC3b-ABP-F complexes inhibited the proliferation of human tumor cell line TPC-1 in vitro.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D008297 Male Males
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D003170 Complement Pathway, Alternative Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE (C3BBB) which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE (C3BBB3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Alternative Complement Pathway,Properdin Pathway,Alternative Complement Activation Pathway,Complement Activation Pathway, Alternative
D003179 Complement C3b The larger fragment generated from the cleavage of COMPLEMENT C3 by C3 CONVERTASE. It is a constituent of the ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb), and COMPLEMENT C5 CONVERTASES in both the classical (C4b2a3b) and the alternative (C3bBb3b) pathway. C3b participates in IMMUNE ADHERENCE REACTION and enhances PHAGOCYTOSIS. It can be inactivated (iC3b) or cleaved by various proteases to yield fragments such as COMPLEMENT C3C; COMPLEMENT C3D; C3e; C3f; and C3g. C3b Complement,C3bi,Complement 3b,Complement Component 3b,Inactivated C3b,iC3b,C3b, Complement,C3b, Inactivated,Complement, C3b,Component 3b, Complement
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

S Shimizu, and H Kitada, and H Yokota, and J Yamakawa, and T Murayama, and K Sugiyama, and H Izumi, and N Yamaguchi
Cheilitis due to Agaricus blazei Murill mushroom extract.
May 2007, Contact dermatitis,
S Shimizu, and H Kitada, and H Yokota, and J Yamakawa, and T Murayama, and K Sugiyama, and H Izumi, and N Yamaguchi
Interleukin-12- and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill.
June 2007, Immunology,
S Shimizu, and H Kitada, and H Yokota, and J Yamakawa, and T Murayama, and K Sugiyama, and H Izumi, and N Yamaguchi
Effects of selenium-enriched Agaricus blazei Murill on liver metabolic dysfunction in mice, a comparison with selenium-deficient Agaricus blazei Murill and sodium selenite.
July 2014, Biological trace element research,
S Shimizu, and H Kitada, and H Yokota, and J Yamakawa, and T Murayama, and K Sugiyama, and H Izumi, and N Yamaguchi
Immunomodulatory effects of Agaricus blazei Murill in Balb/cByJ mice.
June 2007, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
S Shimizu, and H Kitada, and H Yokota, and J Yamakawa, and T Murayama, and K Sugiyama, and H Izumi, and N Yamaguchi
Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
December 2011, Parasitology international,
S Shimizu, and H Kitada, and H Yokota, and J Yamakawa, and T Murayama, and K Sugiyama, and H Izumi, and N Yamaguchi
Assessment of antioxidant and antidiabetic properties of Agaricus blazei Murill extracts.
January 2020, Food science & nutrition,
S Shimizu, and H Kitada, and H Yokota, and J Yamakawa, and T Murayama, and K Sugiyama, and H Izumi, and N Yamaguchi
Effect of Agaricus blazei Murill on exploratory behavior of mice-model.
January 2021, Brazilian journal of biology = Revista brasleira de biologia,
S Shimizu, and H Kitada, and H Yokota, and J Yamakawa, and T Murayama, and K Sugiyama, and H Izumi, and N Yamaguchi
Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis.
October 2012, Parasitology research,
S Shimizu, and H Kitada, and H Yokota, and J Yamakawa, and T Murayama, and K Sugiyama, and H Izumi, and N Yamaguchi
Regulation of RAW 264.7 cell-mediated immunity by polysaccharides from Agaricus blazei Murill via the MAPK signal transduction pathway.
April 2017, Food & function,
S Shimizu, and H Kitada, and H Yokota, and J Yamakawa, and T Murayama, and K Sugiyama, and H Izumi, and N Yamaguchi
Agaricus blazei Murill extract abrogates CCl4-induced liver injury in rats.
January 2011, In vivo (Athens, Greece),
Copied contents to your clipboard!